CrossrefInfokarte
Vericiguat combined with standard therapy improves cardiac function, inflammatory markers, and exercise tolerance in patients with essential hypertension and chronic heart failure
American Journal of Translational Research · 2026 · 18 (10) · 9530-9541
DOI: 10.62347/cqek6090 ↗Abstract
Kein Abstract verfügbar.
EUVIMED